BioMarin Pharmaceutical, Inc. (BMRN)
65.04
-1.66
(-2.50%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Debt to Equity Ratio : 0.6672 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6672 |
| March 31, 2026 | 0.2328 |
| December 31, 2025 | 0.1056 |
| September 30, 2025 | 0.1009 |
| June 30, 2025 | 0.1015 |
| March 31, 2025 | 0.1053 |
| December 31, 2024 | 0.1148 |
| September 30, 2024 | 0.1127 |
| June 30, 2024 | 0.208 |
| March 31, 2024 | 0.2161 |
| December 31, 2023 | 0.229 |
| September 30, 2023 | 0.2218 |
| June 30, 2023 | 0.2269 |
| March 31, 2023 | 0.2327 |
| December 31, 2022 | 0.2433 |
| September 30, 2022 | 0.2368 |
| June 30, 2022 | 0.24 |
| March 31, 2022 | 0.246 |
| December 31, 2021 | 0.263 |
| September 30, 2021 | 0.2527 |
| June 30, 2021 | 0.2539 |
| March 31, 2021 | 0.2586 |
| December 31, 2020 | 0.2755 |
| September 30, 2020 | 0.3712 |
| June 30, 2020 | 0.4639 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2819 |
| December 31, 2019 | 0.2913 |
| September 30, 2019 | 0.2956 |
| June 30, 2019 | 0.305 |
| March 31, 2019 | 0.3037 |
| December 31, 2018 | 0.2798 |
| September 30, 2018 | 0.4118 |
| June 30, 2018 | 0.413 |
| March 31, 2018 | 0.4214 |
| December 31, 2017 | 0.4182 |
| September 30, 2017 | 0.4144 |
| June 30, 2017 | 0.2419 |
| March 31, 2017 | 0.2495 |
| December 31, 2016 | 0.247 |
| September 30, 2016 | 0.2554 |
| June 30, 2016 | 0.3495 |
| March 31, 2016 | 0.2917 |
| December 31, 2015 | 0.2759 |
| September 30, 2015 | 0.2913 |
| June 30, 2015 | 0.2807 |
| March 31, 2015 | 0.2703 |
| December 31, 2014 | 0.4306 |
| September 30, 2014 | 0.4355 |
| June 30, 2014 | 0.4452 |
| March 31, 2014 | 0.453 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Incyte Corp. | 0.006 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Ionis Pharmaceuticals, Inc. | 4.978 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.72B |
| Total Liabilities (Quarterly) | 5.402B |
| Shareholders Equity (Quarterly) | 6.322B |
| Current Ratio | 2.387 |
| Net Debt Paydown Yield | -6.52% |